Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Transformed cell lines susceptible or resistant to in vivo surveillance against tumorigenesis.

× No keyword cloud information.

32 in total

1. Expression of mouse Tla region class I genes in tissues enriched for gamma delta cells.

Authors: P Eghtesady; K A Brorson; H Cheroutre; R E Tigelaar; L Hood; M Kronenberg
Journal: Immunogenetics Date: 1992 Impact factor: 2.846

2. Serum amyloid A protein-related mRNA expression in herpes simplex virus type 2-transformed hamster cells.

Authors: C Gervais; M Suh
Journal: Mol Cell Biol Date: 1990-08 Impact factor: 4.272

3. Metastatic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction.

Authors: Z Chen; C W Smith; D Kiel; C Van Waes
Journal: Clin Exp Metastasis Date: 1997-09 Impact factor: 5.150

4. Reduced natural cytotoxic cell activity in patients receiving cisplatin-based chemotherapy and in mice treated with cisplatin.

Authors: C B Powell; D G Mutch; M S Kao; J L Collins
Journal: Clin Exp Immunol Date: 1990-03 Impact factor: 4.330

5. Expression of the inlAB operon by Listeria monocytogenes is not required for entry into hepatic cells in vivo.

Authors: S H Gregory; A J Sagnimeni; E J Wing
Journal: Infect Immun Date: 1996-10 Impact factor: 3.441

6. The anticancer drug, cisplatin, increases the naturally occurring cell-mediated lysis of tumor cells.

Authors: J L Collins; M S Kao
Journal: Cancer Immunol Immunother Date: 1989 Impact factor: 6.968

7. Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.

Authors: Masafumi Shimoda; Yoshito Tomimaru; Kevin P Charpentier; Howard Safran; Rolf I Carlson; Jack Wands
Journal: J Hepatol Date: 2012-01-13 Impact factor: 25.083

8. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.

Authors: Sadamu Homma; Hideo Komita; Yukiko Sagawa; Tsuneya Ohno; Gotaro Toda
Journal: Immunology Date: 2005-08 Impact factor: 7.397

9. Analysis of a new class I gene mapping to the Hmt region of the mouse.

Authors: K A Brorson; S Richards; S W Hunt; H Cheroutre; K F Lindahl; L Hood
Journal: Immunogenetics Date: 1989 Impact factor: 2.846

10. Definitive localization of intracellular proteins: Novel approach using CRISPR-Cas9 genome editing, with glucose 6-phosphate dehydrogenase as a model.

Authors: Netanya Y Spencer; Ziying Yan; Le Cong; Yulong Zhang; John F Engelhardt; Robert C Stanton
Journal: Anal Biochem Date: 2015-11-11 Impact factor: 3.365